Atlas Trials

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00503880 · TERMINATED

Trial details

NCT number
NCT00503880
Sponsor
University of Nebraska
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2007-05-07
Primary completion
2009-10-13
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.